KAO JOHN E 4
4 · Alignment Healthcare, Inc. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
Alignment Healthcare (ALHC) CEO John Kao Sells 118,000 Shares
What Happened John E. Kao, CEO of Alignment Healthcare, sold 118,000 shares on 2026-03-23 in an open-market/private sale for a total of $2,062,439. The filing reports a weighted-average sale price of $17.48 per share; individual trades ranged from $17.07 to $17.81.
Key Details
- Transaction date: 2026-03-23; weighted-average price $17.48; price range $17.07–$17.81 (multiple trades).
- Total proceeds: $2,062,439.
- Shares owned after transaction: not specified in the provided filing summary; the filing indicates the shares were held by the JEK Trust (see footnote).
- Footnotes: F1 — sale executed under a Rule 10b5-1 plan adopted 11/21/2025; F2 — weighted-average price with per-trade range, detailed breakdown available on request; F3 — shares held by JEK Trust (dated Feb 8, 2021), of which Mr. Kao is trustee.
- Filing timeliness: Form 4 filed for the report dated 2026-03-23 (no late filing flagged).
Context
- This is a sale (often routine) and was carried out under a pre-established 10b5-1 trading plan, which typically allows insiders to sell shares on a preset schedule regardless of subsequent company news.
- The filing does not indicate option exercises, gifts, or tax-withholding; it reports a straight sale of shares.
Insider Transaction Report
Form 4
KAO JOHN E
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-03-23$17.48/sh−118,000$2,062,439→ 2,354,641 total(indirect: See Footnote)
Holdings
- 1,784,868
Common Stock
Footnotes (3)
- [F1]Date of Rule 10b5-1 plan adoption: 11/21/25
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.07 to $17.81. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao|2026-03-23